수의용 비타민 제조 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 제품별, 유형별, 제형별, 밸류체인별, 지역별 및 부문별 예측(2026-2033년)

Veterinary Vitamin Manufacturing Market Summary

The global veterinary vitamin manufacturing market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 2.9 billion by 2033, at a CAGR of 8.7% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest revenue share of 36.5% in 2025. The market growth is driven by its large livestock and poultry population, rising companion animal ownership, increasing adoption of preventive animal healthcare, and growing demand for feed-grade vitamin premixes.

In addition, advanced feed manufacturing infrastructure, stringent animal welfare and food safety regulations, antimicrobial stewardship initiatives, higher pet healthcare expenditure, and the strong presence of leading animal nutrition and veterinary health manufacturers further support sustained growth of the veterinary vitamin manufacturing industry.

Market Dynamics

The veterinary vitamin manufacturing market is experiencing steady growth, driven by increasing livestock production, rising companion animal ownership, and greater emphasis on preventive animal healthcare. In addition, growing awareness of nutritional deficiencies and their impact on animal productivity, immunity, and reproductive performance has increased demand for species-specific vitamin formulations. The expanding adoption of precision livestock farming, fortified feed additives, and customized nutritional supplements further supports market expansion. In addition, increasing investments in animal nutrition research, advancements in microencapsulation and controlled-release technologies, and the development of multifunctional vitamin blends are enhancing product efficacy and stability.

Furthermore, regulatory emphasis on animal welfare, feed quality, and food safety is encouraging manufacturers to produce high-quality, compliant vitamin products. In addition, growing demand for antibiotic alternatives has also accelerated the use of vitamins to improve immune health and disease resistance. Moreover, strategic collaborations, capacity expansions, and investments by leading animal nutrition companies are strengthening global manufacturing capabilities, enabling wider product availability and supporting sustained market growth across both developed and emerging economies.

Global Veterinary Vitamin Manufacturing Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary vitamin manufacturing market report based on animal, product, type, dosage form, value chain, and region:

• Animal Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Companion Animals
• Production Animals
• Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Vitamin B-Complex
• Vitamin B12
• Vitamin K
• Vitamin D3
• Other Vitamins
• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• API
• Finished Drug Products
• Dosage Form Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Oral
• Injectables
• Value Chain Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Pharmaceutical & Biopharmaceutical Companies
• Animal Feed & Nutrition Companies
• CMO/CDMOs
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Product
  • 1.2.3. Type
  • 1.2.4. Dosage Form
  • 1.2.5. Value Chain
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Bottom-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising Companion Animal Ownership
    • 3.2.1.2. Increasing Adoption of Preventive Animal Healthcare
    • 3.2.1.3. Growing Demand for Feed-Grade Vitamin Premixes
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Vitamin Stability and Degradation Challenges
    • 3.2.2.2. Limited Awareness and Inconsistent Adoption of Preventive Animal Nutrition
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Technology Landscape
• 3.4. Price & Cost Structure Analysis
• 3.5. Tariff & Trade Impact Analysis
• 3.6. Value Chain Analysis
  • 3.6.1. Supply Trends
  • 3.6.2. Demand Trends
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Force Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Veterinary Vitamin Manufacturing Market: Animal Estimates & Trend Analysis

• 4.1. Veterinary Vitamin Manufacturing Market by Animal, Segment Dashboard
• 4.2. Veterinary Vitamin Manufacturing Market: Animal Movement Analysis
• 4.3. Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million/Billion)
• 4.4. Production Animals
  • 4.4.1. Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 4.5. Companion Animals
  • 4.5.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 5. Veterinary Vitamin Manufacturing Market: Product Estimates & Trend Analysis

• 5.1. Veterinary Vitamin Manufacturing Market by Product, Segment Dashboard
• 5.2. Veterinary Vitamin Manufacturing Market: Product Movement Analysis
• 5.3. Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million/Billion)
• 5.4. Vitamin B-complex
  • 5.4.1. Vitamin B-complex Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 5.5. Vitamin B12
  • 5.5.1. Vitamin B12 Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 5.6. Vitamin K
  • 5.6.1. Vitamin K Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 5.7. Vitamin D3
  • 5.7.1. Vitamin D3 Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 5.8. Other Vitamins
  • 5.8.1. Other Vitamins Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 6. Veterinary Vitamin Manufacturing Market: Type Estimates & Trend Analysis

• 6.1. Veterinary Vitamin Manufacturing Market by Type, Segment Dashboard
• 6.2. Veterinary Vitamin Manufacturing Market: Type Movement Analysis
• 6.3. Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million/Billion)
• 6.4. API
  • 6.4.1. API Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.5. Finished Drug Products
  • 6.5.1. Finished Drug Products Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Veterinary Vitamin Manufacturing Market: Dosage Form Estimates & Trend Analysis

• 7.1. Veterinary Vitamin Manufacturing Market by Dosage Form, Segment Dashboard
• 7.2. Veterinary Vitamin Manufacturing Market: Dosage Form Movement Analysis
• 7.3. Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Dosage Form, 2021 to 2033 (USD Million/Billion)
• 7.4. Oral
  • 7.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 7.5. Injectables
  • 7.5.1. Injectables Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 8. Veterinary Vitamin Manufacturing Market: Value Chain Estimates & Trend Analysis

• 8.1. Veterinary Vitamin Manufacturing Market by Value Chain, Segment Dashboard
• 8.2. Veterinary Vitamin Manufacturing Market: Value Chain Movement Analysis
• 8.3. Veterinary Vitamin Manufacturing Market Size & Trend Analysis, by Value Chain, 2021 to 2033 (USD Million/Billion)
• 8.4. Pharmaceutical & Biopharmaceutical Companies
  • 8.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.5. Animal Feed & Nutrition Companies
  • 8.5.1. Animal Feed & Nutrition Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.6. CMO/CDMOs
  • 8.6.1. CMO/CDMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.7. Others
  • 8.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 9. Veterinary Vitamin Manufacturing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Dashboard
• 9.2. Regional Market Share Analysis, 2025 & 2033
• 9.3. North America
  • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.2. U.S
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.4. Europe
  • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.6. Latin America
  • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.7. MEA
  • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.3. UAE
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.4. Saudi Arabia
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.6. Qatar
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
  • 9.7.7. Oman
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 10. Competitive Landscape

• 10.1. Key Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
• 10.3. Company Profiles
  • 10.3.1. Merck & Co., Inc.
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Zoetis
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Virbac
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Boehringer Ingelheim International GmbH
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Elanco
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Phibro Animal Health Corporation
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Intas Pharmaceuticals
    • 10.3.7.1. Company Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Vandana Biotech Private Limited
    • 10.3.8.1. Company Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Abbey Labs
    • 10.3.9.1. Company Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Vetnil
    • 10.3.10.1. Company Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives